Skip to main content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Huisarts en wetenschap 9/2015

01-09-2015 | Kleinekwaal

Gastro-oesofageale reflux bij zuigelingen

Auteurs: Hannebeth Bosker, dr. Just Eekhof, dr. Ram Sukhai, dr. Arie Knuistingh Neven

Gepubliceerd in: Huisarts en wetenschap | Uitgave 9/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Bij gastro-oesofageale reflux is er terugvloed van maaginhoud in de slokdarm, met of zonder regurgitatie en spugen. Als dit asymptomatisch is, is er sprake van gastro-oesofageale reflux (GER). Van gastro-oesofageale refluxziekte (GERZ) wordt gesproken als het leidt tot hinderlijke klachten en/of complicaties bij de zuigeling, zoals prikkelbaar gedrag, voedselweigering, groeivertraging, het opgeven van bloedsliertjes, slaapproblemen, apparent life threatening episodes (ALTE), et cetera.1
Literatuur
go back to reference Allen K, Ho SSC. Gastro-oesophageal reflux in children, what's the worry? Aust Fam Physician 2012;41:268–72. PubMed Allen K, Ho SSC. Gastro-oesophageal reflux in children, what's the worry? Aust Fam Physician 2012;41:268–72. PubMed
go back to reference Tabbers MM (voorzitter Werkgroep) Richtlijn: Gastro-oesofageale reflux(ziekte) bij kinderen van 0-18 jaar. Nederlandse Vereniging voor Kindergeneeskunde. Jul 2012. Tabbers MM (voorzitter Werkgroep) Richtlijn: Gastro-oesofageale reflux(ziekte) bij kinderen van 0-18 jaar. Nederlandse Vereniging voor Kindergeneeskunde. Jul 2012.
go back to reference Blanco FC, Davenport KP, Kane TD. Pediatric gastroesophageal reflux disease. Surgical Clinics of North America 2012;92:541–58. CrossRefPubMed Blanco FC, Davenport KP, Kane TD. Pediatric gastroesophageal reflux disease. Surgical Clinics of North America 2012;92:541–58. CrossRefPubMed
go back to reference Loots C, Kritas S, Van Wijk M, McCall L, Peeters L, Lewindon P, et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr 2014;59:237–43. CrossRefPubMed Loots C, Kritas S, Van Wijk M, McCall L, Peeters L, Lewindon P, et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr 2014;59:237–43. CrossRefPubMed
go back to reference Craig WR, Hanlon-Dearman A, Sinclair C, Taback S, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003502. Craig WR, Hanlon-Dearman A, Sinclair C, Taback S, Moffatt M. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003502.
go back to reference Jung WJ, Yang HJ, Min TK, Jeon YH, Lee HW, Lee JS, et al. The efficacy of the upright position on gastro-esophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res 2012;4:17–23. PubMedCentralCrossRefPubMed Jung WJ, Yang HJ, Min TK, Jeon YH, Lee HW, Lee JS, et al. The efficacy of the upright position on gastro-esophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res 2012;4:17–23. PubMedCentralCrossRefPubMed
go back to reference Vandenplas Y, De Schepper J, Verheyden S, Devreker T, Franckx J, Peelman M, et al. A preliminary report on the efficacy of the Multicare AR-Bed in 3-week-3-month-old infants on regurgitation, associated symptoms and acid reflux. Arch Dis Child 2010;95:26–30. CrossRefPubMed Vandenplas Y, De Schepper J, Verheyden S, Devreker T, Franckx J, Peelman M, et al. A preliminary report on the efficacy of the Multicare AR-Bed in 3-week-3-month-old infants on regurgitation, associated symptoms and acid reflux. Arch Dis Child 2010;95:26–30. CrossRefPubMed
go back to reference Vandenplas, Y. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pedicatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498–547. CrossRefPubMed Vandenplas, Y. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pedicatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498–547. CrossRefPubMed
go back to reference Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008;122:e1268–77 CrossRefPubMed Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008;122:e1268–77 CrossRefPubMed
go back to reference Van der Pol R, Langendam M, Benninga M, Van Wijk M, Tabbers M. Efficacy and safety of histamine-2 receptor antagonists. JAMA Pediatr 2014;168:947–54. CrossRefPubMed Van der Pol R, Langendam M, Benninga M, Van Wijk M, Tabbers M. Efficacy and safety of histamine-2 receptor antagonists. JAMA Pediatr 2014;168:947–54. CrossRefPubMed
go back to reference Van der Pol RJ, Smits MJ, Van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 2011;127:925–35. CrossRefPubMed Van der Pol RJ, Smits MJ, Van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics 2011;127:925–35. CrossRefPubMed
go back to reference Khoshoo V, Dhume P. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2008;46:352–4 CrossRefPubMed Khoshoo V, Dhume P. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2008;46:352–4 CrossRefPubMed
go back to reference Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44:41–4. CrossRefPubMed Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr 2007;44:41–4. CrossRefPubMed
go back to reference Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514–20. CrossRefPubMed Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514–20. CrossRefPubMed
go back to reference Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 2003;143:219–23. CrossRefPubMed Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 2003;143:219–23. CrossRefPubMed
go back to reference Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr 2010;50:609–18 CrossRefPubMed Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr 2010;50:609–18 CrossRefPubMed
go back to reference Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, et al. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. J Pediatr 2013;163:692–8. CrossRefPubMed Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, et al. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. J Pediatr 2013;163:692–8. CrossRefPubMed
go back to reference Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M. Esomeprazole for the treatment of GERD in infants ages 1-11 months. J Pediatr Gastroenterol Nutr 2012;55:14–20. CrossRefPubMed Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M. Esomeprazole for the treatment of GERD in infants ages 1-11 months. J Pediatr Gastroenterol Nutr 2012;55:14–20. CrossRefPubMed
Metagegevens
Titel
Gastro-oesofageale reflux bij zuigelingen
Auteurs
Hannebeth Bosker
dr. Just Eekhof
dr. Ram Sukhai
dr. Arie Knuistingh Neven
Publicatiedatum
01-09-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Huisarts en wetenschap / Uitgave 9/2015
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912
DOI
https://doi.org/10.1007/s12445-015-0259-2

Andere artikelen Uitgave 9/2015

Huisarts en wetenschap 9/2015 Naar de uitgave